Ritrovato Charles 4
4 · NEUROGEN CORP · Filed May 25, 2004
Insider Transaction Report
Form 4
NEUROGEN CORPNRGN
Ritrovato Charles
SR VP Drug Regulatory Affairs
Transactions
- Award
Stock Options (Right to Buy)
2004-05-21+50,000→ 0 totalExercise: $9.50From: 2005-05-21→ Common Stock par value $.025 (50,000 underlying)
Footnotes (1)
- [F1]On 05/21/2004 the reporting person was granted an option to purchase 50,000 shares of common stock pursuant to the Amended and Restated 2001 Neurogen Stock Option Plan. The options vest in four equal annual installments and expire 5 years from each vesting date.